Default company panoramic image
Logo

Specialty Pharmaceutical Products

SPP creates new 505(b)2 enhanced and branded pharmaceutical products with significant advantages compared to existing Blockbuster drugs.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Tullytown, PA, USA
  • Currency USD
  • Founded January 2009
  • Employees 10
  • Website pharmsolv.com

Company Summary

SPP's Enhanced Pharmaceuticals (EPs) will serve as superior products and provide significant cost savings for insurance and government programs, even when generic alternatives exist. EPs combine proven drug substances with SPP's proven drug delivery systems to achieve better delivery and performance of a drug, such as faster onset of action ("works faster") for migraine relief or rapid response medicines in the fight against bioterrorism.

Team

  • Default avatar
    Ronald Harland
    President

    Owner of SPP and PharmSolv, and is an advanced drug delivery systems industry leader. Dr. Harland has worked in the field of pharmaceutical product development and with advanced drug delivery systems for over 20 years where he has developed more than 75 products. Dr. Harland has started and grown 2 international drug delivery companies, PharmSolv and Gattec.

  • Default avatar
    Charles Plumb
    Executive Vice President

    He has served as the Chief Development Officer (CDO) for a number of prominent Texas families including the Bass Family (Richard Rainwater). He has been the President and Chief Operating Officer of two ASE/AMEX listed companies and has held the position of Executive Vice President for NYSE listed American Hotels and Realty Corporation.

  • Default avatar
    Robert Mills
    Advisor

    Mr. Mills orchestrated the $1.4 Billion acquisition of Qualitest Rx by Endo Pharmaceutical in 2010 as CEO of Qualitest Rx. He previously ran Columbia Laboratories as President and Chief Executive Officer, and more than quadrupling the value of Columbia Laboratories. Mr. Mills has over 30 years of professional experience at the executive management level in corporate direction and operations with both branded and major generic companies.

  • Default avatar
    David Lewis
    Chief Quality Officer

    Dr. Lewis has directed the analytical laboratories at Genzyme Corporation in Farmingham, Massachusetts. Dr. Lewis has over 25 years of experience in analytical research, quality control and quality assurance. Prior to Genzyme, he was the Vice President of Quality Control for Ivax Corporation (now Teva Pharmaceutical Ltd.).

Advisors

  • Default avatar
    Morgan Lewis
    Lawyer
    Unconfirmed
    Default avatar
    Sobel & associates
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    Owner
    Unconfirmed
    Default avatar
    Management
    Unconfirmed
    Default avatar
    Client Major Phamraceutical Companies (i.e. Merck, Novartis, etc.)
    Unconfirmed